Burosumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Burosumab and local guidelines before prescribing.

Anti-FGF23 antibody

Mechanism

Anti-FGF23 monoclonal antibody.

Uses

X-linked hypophosphataemia, tumour-induced osteomalacia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Injection-site reactions, hyperphosphataemia, headache.

Interactions

Phosphate supplements and active vitamin D contraindicated.

Contraindications and cautions

Severe renal impairment

Monitoring

Phosphate, PTH

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Contraindicated in severe renal impairment

Overdose and reversal

Supportive

Special advice

Monitor phosphate and calcium.

More from the textbook: uses, cautions and other points
Where it is discussed in the book